BioLineRx Falls Most in 2 Weeks, Narrows Gap With U.S. Stock

Feb. 7 (Bloomberg) -- BioLineRx Ltd. slid the most in almost two weeks, narrowing the gap with the biophamaceutical company’s American depositary receipts.

The shares slumped 11 percent, the most since Jan. 26, to 1.66 shekels, or the equivalent of 45 cents, at the 4:30 p.m. close in Tel Aviv. The company’s ADRs, each representing 10 shares, closed at $4.44 yesterday in New York.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at

To contact the editor responsible for this story: Claudia Maedler at